GLH — Global Health Income Statement
0.000.00%
Last trade - 00:00- AU$5.75m
- AU$4.91m
- AU$8.67m
- 46
- 79
- 31
- 53
Annual income statement for Global Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.26 | 7.03 | 6.54 | 7.82 | 8.67 |
| Cost of Revenue | |||||
| Gross Profit | 5 | 5.38 | 4.86 | 6.25 | 7.04 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6.39 | 7.6 | 8.51 | 15.4 | 9.88 |
| Operating Profit | -0.132 | -0.564 | -1.98 | -7.63 | -1.22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.242 | -0.626 | -2.01 | -7.7 | -1.31 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.06 | -0.488 | -2.05 | -8.05 | -1.31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.06 | -0.488 | -2.05 | -8.05 | -1.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.06 | -0.488 | -2.05 | -8.05 | -1.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.002 | -0.003 | -0.037 | -0.096 | -0.023 |
| Dividends per Share |